TY - JOUR
T1 - Novel mutation in VCP gene causes atypical amyotrophic lateral sclerosis
AU - González-Pérez, Paloma
AU - Cirulli, Elizabeth T.
AU - Drory, Vivian E.
AU - Dabby, Ron
AU - Nisipeanu, Puiu
AU - Carasso, Ralph L.
AU - Sadeh, Menachem
AU - Fox, Andrew
AU - Festoff, Barry W.
AU - Sapp, Peter C.
AU - McKenna-Yasek, Diane
AU - Goldstein, David B.
AU - Brown, Robert H.
AU - Blumen, Sergiu C.
N1 - Funding Information:
Supported by National Institute for Neurological Disease and Stroke (grants 1RC2NS070342-02 to R.H.B. and D.G.; 5RO1-NS050557-05 to R.H.B.) . R.H.B. also receives support from the Angel Fund, the ALS Association, Project ALS, P2ALS, Pierre L. de Bourgknecht ALS Research Foundation, the Al-Athel ALS Foundation, and the ALS Therapy Alliance. P.G.-P. receives support from the Alfonso Martin Escudero Foundation (Madrid). P.S. was supported through the auspices of Dr. H. Robert Horvitz, an Investigator at the Howard Hughes Medical Institute in the Department of Biology at the Massachusetts Institute of Technology.
PY - 2012/11/27
Y1 - 2012/11/27
N2 - Objective: To identify the genetic variant that causes autosomal dominantly inheritedmotor neuron disease in a 4-generation Israeli-Arab family using genetic linkage and whole exome sequencing. Methods: Genetic linkage analysis was performed in this family using Illumina single nucleotide polymorphism chips. Whole exome sequencing was then undertaken onDNAsamples from2affected family members using an Illumina 2000 HiSeq platform in pursuit of potentially pathogenic genetic variants that comigrate with the disease in this pedigree. Variants meeting these criteria were then screened in all affected individuals. Results: A novel mutation (p.R191G) in the valosin-containing protein (VCP) gene was identified in the index family. Direct sequencing of the VCP gene in a panel of DNA from 274 unrelated individuals with familial amyotrophic lateral sclerosis (FALS) revealed 5 additional mutations. Among them, 2 were previously identified in pedigrees with a constellation of inclusion body myopathy with Paget disease of the bone and frontotemporal dementia (IBMPFD) and in FALS, and 2 other mutations (p.R159C and p.R155C) in IBMPFD alone.We did not detect VCP genemutations in DNA from 178 cases of sporadic amyotrophic lateral sclerosis. Conclusions: We report a novel VCP mutation identified in an amyotrophic lateral sclerosis family (p.R191G) with atypical clinical features. In our experience, VCP mutations arise in approximately 1.5% of FALS cases. Our study supports the view that motor neuron disease is part of the clinical spectrum of VCP-associated disease.
AB - Objective: To identify the genetic variant that causes autosomal dominantly inheritedmotor neuron disease in a 4-generation Israeli-Arab family using genetic linkage and whole exome sequencing. Methods: Genetic linkage analysis was performed in this family using Illumina single nucleotide polymorphism chips. Whole exome sequencing was then undertaken onDNAsamples from2affected family members using an Illumina 2000 HiSeq platform in pursuit of potentially pathogenic genetic variants that comigrate with the disease in this pedigree. Variants meeting these criteria were then screened in all affected individuals. Results: A novel mutation (p.R191G) in the valosin-containing protein (VCP) gene was identified in the index family. Direct sequencing of the VCP gene in a panel of DNA from 274 unrelated individuals with familial amyotrophic lateral sclerosis (FALS) revealed 5 additional mutations. Among them, 2 were previously identified in pedigrees with a constellation of inclusion body myopathy with Paget disease of the bone and frontotemporal dementia (IBMPFD) and in FALS, and 2 other mutations (p.R159C and p.R155C) in IBMPFD alone.We did not detect VCP genemutations in DNA from 178 cases of sporadic amyotrophic lateral sclerosis. Conclusions: We report a novel VCP mutation identified in an amyotrophic lateral sclerosis family (p.R191G) with atypical clinical features. In our experience, VCP mutations arise in approximately 1.5% of FALS cases. Our study supports the view that motor neuron disease is part of the clinical spectrum of VCP-associated disease.
UR - https://www.scopus.com/pages/publications/84871331678
U2 - 10.1212/WNL.0b013e318275963b
DO - 10.1212/WNL.0b013e318275963b
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
AN - SCOPUS:84871331678
SN - 0028-3878
VL - 79
SP - 2201
EP - 2208
JO - Neurology
JF - Neurology
IS - 22
ER -